Contact the editorial desk

Corrections and citations

The most valuable message this desk receives is a correction. A claim quoted more confidently than its source supports, a study that has since been retracted or superseded, a regulatory status that has changed, or a peer-reviewed paper on GHK-Cu, the GLOW constituents or melanocortin analogs that belongs on the references page — all of these improve the site immediately.

Corrections are easiest to act on when they name three things: which page, the exact sentence in question, and the supporting source. In that shape a passage can be checked against the literature before anything is rewritten.

Editorial mailbox: editors@peptidebarbie.com

Out of scope

So that no message goes unanswered for the wrong reason, several categories sit outside what this desk does:

• Advising on, endorsing or discouraging human use of any compound covered here.
• Naming a dose, schedule, route or protocol for any individual.
• Judging whether a cited finding applies to a particular person or situation.
• Sourcing, comparing, recommending or helping locate a supplier or product.
• Interpreting symptoms, side effects or personal results.

A new or changing mole, or any symptom arising during or after use of the compounds described here, is a matter for a clinician rather than a mailbox — the published case-report literature is emphatic on that point ^[12]. Replies are not guaranteed and can be slow; the mailbox is read in batches.